stockrowTrulieve Cannabis Corp.
TRLV Healthcare Drug Manufacturers Specialty & Generic
Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.
- Revenue
- −20.1%
- EPS
- −2,391.1%
- Free cash flow
- +24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow TRLV
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | |
|---|---|---|---|---|---|---|
Cash and Short Term Investments |
255.54 | 300.10 | 207.98 | 213.79 | 233.10 | — |
Receivables |
18.96 | 18.30 | 6.70 | 6.51 | 8.60 | — |
Inventory |
242.30 | 231.37 | 213.12 | 276.51 | 209.94 | — |
Other current assets |
25.50 | 26.21 | 23.74 | 51.25 | — | — |
Total current assets |
562.72 | 604.56 | 477.35 | 593.54 | 524.93 | — |
Property, Plant, Equpment (Net) |
670.44 | 716.05 | 676.35 | 743.26 | 779.41 | — |
Long-term receivables |
0.45 | 0.53 | 7.42 | 11.99 | 12.15 | — |
Goodwill and Intangible Assets (Total) |
1,282.27 | 1,343.39 | 1,401.10 | 1,776.29 | 1,846.60 | 0.00 |
Long-term assets (Other) |
10.02 | 19.84 | 10.38 | 12.77 | 17.64 | — |
Total non-current assets |
2,133.38 | 2,265.71 | 2,251.71 | 2,806.86 | 2,886.45 | — |
Total Assets |
2,696.10 | 2,870.27 | 2,729.06 | 3,400.41 | 3,411.38 | — |
Notes Payable |
4.08 | 3.41 | 3.76 | 12.45 | 10.05 | — |
Accounts Payable |
82.66 | 94.04 | 83.16 | 82.02 | 93.80 | — |
Current Part of Capital Lease |
10.70 | 9.54 | 7.64 | 8.27 | 6.19 | 0.00 |
Current Part of Taxes to Pay |
— | — | — | 49.62 | 28.08 | 0.00 |
Current Revenue (Deferred) |
9.59 | 8.03 | 1.34 | 9.46 | 7.21 | — |
Other current liabilities |
3.21 | 8.23 | 5.90 | 35.86 | 14.01 | — |
Total current liabilities |
126.95 | 138.49 | 114.85 | 210.30 | 169.45 | — |
Long Term Debt (Total) |
291.72 | 544.46 | 540.75 | 705.86 | 534.63 | — |
Non-current Revenue (Deferred) |
— | — | — | — | — | 0.00 |
Long Term Tax Liability (Deferred) |
177.99 | 196.55 | 206.96 | 224.90 | 241.88 | — |
Minority Interests |
— | — | — | — | — | 0.00 |
Non-current Liabilities (Other) |
813.61 | 585.70 | 324.10 | 163.42 | 186.49 | — |
Total non-current liabilities |
1,426.14 | 1,482.75 | 1,205.59 | 1,262.41 | 1,094.56 | — |
Total liabilities |
1,553.09 | 1,621.24 | 1,320.44 | 1,472.70 | 1,264.01 | — |
Additional Paid In Capital |
2,073.36 | 2,057.03 | 2,055.11 | 2,045.00 | 2,008.10 | 0.00 |
Preferred Stock (Total) |
— | — | — | — | — | 0.00 |
Common Stock (Net) |
— | 0.00 | — | — | — | 0.00 |
Retained Earnings |
(912.12) | (795.74) | (640.64) | (113.84) | 137.72 | — |
Treasury Stock |
— | — | — | — | — | 0.00 |
Shareholders Equity (Other) |
— | — | — | — | — | 0.00 |
Common Equity (Total) |
1,143.01 | 1,249.03 | 1,408.61 | 1,927.70 | 2,147.37 | — |
Shareholders Equity (Total) |
1,143.01 | 1,249.03 | 1,408.61 | 1,927.70 | 2,147.37 | — |
Shareholders Equity and Liabilities (Total) |
2,696.10 | 2,870.27 | 2,729.06 | 3,400.41 | 3,411.38 | — |
Shares (Common) |
— | — | 186.24 | 185.99 | 180.50 | — |
Shareholders Equity (Tangible) |
(139.26) | (94.36) | 7.52 | 151.41 | 300.78 | — |
Net Debt |
36.19 | 244.36 | 332.77 | 492.07 | 301.53 | — |
Total Debt |
291.72 | 544.46 | 540.75 | 705.86 | 534.63 | — |